NCT02831543View on ClinicalTrials.gov

Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.

PHASE3UnknownINTERVENTIONAL
Enrollment

354

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

June 30, 2017

Conditions
Functional Dyspepsia
Interventions
DRUG

Motireb 5/100 mg

DRUG

Mosapride citrate

DRUG

Placebo

Trial Locations (1)

Unknown

RECRUITING

Seoul National University Bundang Hospital, Seongnam

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT02831543 - Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients. | Biotech Hunter | Biotech Hunter